Key result
A single pointed-end mutation (A204C) in yeast actin results in polymerization-deficient phenotypes and modulates the critical concentration of the pointed end of actin.
The A204C mutation in yeast actin modulates the critical concentration of the pointed end, providing a tool for producing short F-actin structures for structural studies.
Answers are grounded in this paper and cite their sources.
May enable short F-actin production for structural studies; hypothesis-generating in yeast and requires mammalian validation.
Characterizing mutants of actin that do not polymerize will advance our understanding of the mechanism of actin polymerization and will be invaluable for the production of short F-actin structures for structural studies. To circumvent the problem of expressing dominant lethal nonpolymerizing actin in yeast, we adopted a cysteine engineering strategy. Here we report the characterization of a mutant of yeast actin, AC-actin, possessing a single pointed-end mutation, A204C. Expression of this mutant in yeast results in actin-polymerization-deficient phenotypes. When copolymerized with wild-type actin, ATP-AC-actin is incorporated into filaments. ADP-AC-actin participates in the nucleation and elongation of wild-type filaments only at very high concentrations. At low concentrations, ADP-AC-actin appears to participate only in the nucleation of wild-type filaments, suggesting that Ala-204 is involved in modulating the critical concentration of the pointed end of actin.
No takes yet. Share an insight, caveat, or question.
Teal et al. (2007) studied this question. A204C mutation in yeast actin (AC-actin) vs. Wild-type actin was evaluated on Actin polymerization and nucleation. A single pointed-end mutation (A204C) in yeast actin results in polymerization-deficient phenotypes and modulates the critical concentration of the pointed end of actin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: